Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham FarmafiledCriticalSmithkline Beecham Farma
Priority to IT93MI002543ApriorityCriticalpatent/IT1280010B1/en
Publication of ITMI932543A0publicationCriticalpatent/ITMI932543A0/en
Publication of ITMI932543A1publicationCriticalpatent/ITMI932543A1/en
Application grantedgrantedCritical
Publication of IT1280010B1publicationCriticalpatent/IT1280010B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Compositions Of Macromolecular Compounds
(AREA)
Abstract
This invention relates to complex therapeutic/polymer matrix agents having improved flavour characteristics and pharmaceutical compositions containing them.
Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it